Skip to main content
. 2023 Jul 22;25:125. doi: 10.1186/s13075-023-03116-5

Fig. 2.

Fig. 2

Correlation between anti-Jo-1 concentration and global (A), pulmonary (B), muscular (C), articular (D), cutaneous (E), cardiological (F), gastrointestinal (G), and constitutional (H) disease activity